Common extensor tendon (CET)

The common extensor tendon (CET) is a major tendinous structure originating from the lateral epicondyle of the humerus, serving as the shared origin for several muscles responsible for wrist and finger extension, including the extensor carpi radialis brevis and extensor digitorum (StatPearls, 2023). It is primarily composed of Type I collagen and tenocytes, which maintain the structural integrity required for force transmission from muscle to bone (Wikipedia, 2024). The CET is the primary anatomical site affected in lateral epicondylitis, or tennis elbow, a condition characterized by degenerative changes and angiofibroblastic hyperplasia resulting from repetitive strain (PubMed, 2022). While the CET is an anatomical tissue rather than a molecular target like a receptor or enzyme, it is the focus of various pharmacological and biological interventions (NIH, 2021). Treatments often involve local administration of corticosteroids to reduce pain, or platelet-rich plasma to promote tissue regeneration and collagen synthesis (Mayo Clinic, 2023). These interventions aim to modulate the local environment of the tendon to alleviate symptoms and improve functional outcomes in patients with chronic tendinopathy (PubMed, 2022).

Other names

Common extensor originCETLateral epicondyle extensor tendon

Pharmacological agents targeting the common extensor tendon environment typically function by inhibiting cyclooxygenase enzymes to reduce prostaglandin synthesis (NSAIDs), activating glucocorticoid receptors to suppress local inflammation (corticosteroids), or providing growth factors to stimulate collagen synthesis and tissue remodeling (PRP) (PubMed, 2022; NIH, 2021).